OpenVSafe by OpenVAERS
Search V-safe

AWM-31588-17995

2 vaccinations 2 coded responses 23 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
550 / MN
Registered
2021-01-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-13
    Registered in v-safe
  2. 2021-01-13
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-13
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-01-21
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-01-27
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-03
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-03
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  13. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  14. 2021-02-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  15. 2021-02-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Redness, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Swelling, Itching · Fatigue or tiredness
    Adult check-in
  17. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Itching · Fatigue or tiredness
    Adult check-in
  18. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  19. 2021-02-10
    Survey response — day 7, dose 2
    MedDRA: Injection site discolouration — Feeling: Good
    Free text: Discoloration of skin around injection site, light bruise color
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-02-17
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-24
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-11
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-19
    Survey response — day 42, dose 2
    MedDRA: Gestational hypertension, Premature delivery — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Gestational HTN causing late pre-term delivery 35 weeks and 2 days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-03-19
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-05-05
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-05-19
  28. 2021-08-04
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-13Pfizer-BioNTech
22021-02-03Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 4 — day 7, dose 2

2021-02-10

Systemic reaction (other): Discoloration of skin around injection site, light bruise color

Release 5 — day 42, dose 2

2021-03-19

Symptoms: Gestational HTN causing late pre-term delivery 35 weeks and 2 days

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDGestational hypertension ✓ ✓ ✓
SDPremature delivery ✓ ✓ ✓
SROInjection site discolouration ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release